Professor, The Institute of Medical Science, University of Tokyo
BIOGRAPHY
Speaker
Abstract
At the end of 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), emerged in China. As of September 2022, SARS-CoV-2 is still ongoing pandemic: more than six hundred million cases of SARS-CoV-2 infection have been reported worldwide, with more than six million people dying of COVID-19. During the spreading worldwide, SARS-CoV-2 has been diversified, and these SARS-CoV-2 variants are considered to be the potential threats to the human society. In this talk, I will introduce our recent findings on a series of SARS-CoV-2 variants.
Learning Objectives:
1. Discuss the current and future situation of COVID-19 pandemic.
2. Explain the impact of novel SARS-CoV-2 variants.
3. Evaluate what we should do to continue to control this pandemic.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
MAY 29, 2024 | 8:00 AM
A-TEEM spectroscopy is an emerging technique with huge potential for QC laboratories in the pharmaceutical and biopharmaceutical industries. We present a set of tools for A-TEEM spectroscopy...
MAY 29, 2024 | 9:00 AM
C.E. CREDITS
Histology laboratorians in the research world move fast, but those who perform cryosectioning know that these particular tissues require lighting speed and precision. Cryosectioning is the a...
MAY 15, 2024 | 10:00 AM
Join this year's poster presenters in the Poster Hall during the Poster Networking Hour, Wednesday, September 6th, from 1:00 –2:00 PM PDT , to chat live about their posters and lat...
JUN 19, 2024 | 8:30 AM
Join us for an illuminating webinar as we delve into the realm of open automation with Inpeco, the global leader in Total Laboratory Automation. Discover how their groundbreaking s...
Loading Comments...